4.6 Article

Anticancer mechanism of peptide P18 in human leukemia K562 cells

Journal

ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 8, Issue 5, Pages 984-987

Publisher

ROYAL SOC CHEMISTRY
DOI: 10.1039/b920762g

Keywords

-

Funding

  1. Sichuan University of Ministry of Education of China
  2. National Nature Science Foundation of China (NSFC) [50775152]

Ask authors/readers for more resources

Studies on the anticancer mechanism of peptide P18 in human leukemia K562 cells revealed that P18 causes the death of most K562 cells by depolarizing plasma membrane potential and enhancing membrane permeability, rather than activating the classical apoptosis pathway. The mechanistic studies indicate that disrupting plasma membrane is an effective approach to kill cancer cells and help design more effective peptide analogues in future cancer therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available